Thyroid Cancer Diagnostic Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: T89C8C8D7C08EN
Market Monitor Global

Abstracts

Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in early stage and progresses with formation of lump in thyroid gland. If diagnosed in early stage it can be treated easily.

This report contains market size and forecasts of Thyroid Cancer Diagnostic in Global, including the following market information:

Global Thyroid Cancer Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Thyroid Cancer Diagnostic market was valued at 2834.7 million in 2021 and is projected to reach US$ 3952.1 million by 2028, at a CAGR of 4.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Papillary Carcinoma Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Thyroid Cancer Diagnostic include Abbott, Roche, Thermo Fisher Scientific, Siemens Healthcare GmbH, Bio-Rad Laboratories, General Electric, Koninklijke Philips, Agilent Technologies and Illumina. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thyroid Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Thyroid Cancer Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Thyroid Cancer Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Papillary Carcinoma
• Follicular Carcinoma
• Others

Global Thyroid Cancer Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Thyroid Cancer Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Hospital Laboratories
• Cancer Diagnostic Centers
• Research Institutes
• Others

Global Thyroid Cancer Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Thyroid Cancer Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thyroid Cancer Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Thyroid Cancer Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Roche
• Thermo Fisher Scientific
• Siemens Healthcare GmbH
• Bio-Rad Laboratories
• General Electric
• Koninklijke Philips
• Agilent Technologies
• Illumina

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Thyroid Cancer Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Thyroid Cancer Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL THYROID CANCER DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Thyroid Cancer Diagnostic Market Size: 2021 VS 2028
2.2 Global Thyroid Cancer Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Thyroid Cancer Diagnostic Players in Global Market
3.2 Top Global Thyroid Cancer Diagnostic Companies Ranked by Revenue
3.3 Global Thyroid Cancer Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Thyroid Cancer Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Thyroid Cancer Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thyroid Cancer Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Thyroid Cancer Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Thyroid Cancer Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Thyroid Cancer Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Papillary Carcinoma
  4.1.3 Follicular Carcinoma
  4.1.4 Others
4.2 By Type - Global Thyroid Cancer Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Thyroid Cancer Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Thyroid Cancer Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Thyroid Cancer Diagnostic Market Size, 2021 & 2028
  5.1.2 Hospital Laboratories
  5.1.3 Cancer Diagnostic Centers
  5.1.4 Research Institutes
  5.1.5 Others
5.2 By Application - Global Thyroid Cancer Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Thyroid Cancer Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Thyroid Cancer Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Thyroid Cancer Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Thyroid Cancer Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Thyroid Cancer Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Thyroid Cancer Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Thyroid Cancer Diagnostic Revenue, 2017-2028
  6.3.2 US Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.3.3 Canada Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Thyroid Cancer Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Thyroid Cancer Diagnostic Revenue, 2017-2028
  6.4.2 Germany Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.4.3 France Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.4.5 Italy Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.4.6 Russia Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Thyroid Cancer Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Thyroid Cancer Diagnostic Revenue, 2017-2028
  6.5.2 China Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.5.3 Japan Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.5.6 India Thyroid Cancer Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Thyroid Cancer Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Thyroid Cancer Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.7.3 Israel Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Thyroid Cancer Diagnostic Market Size, 2017-2028
  6.7.5 UAE Thyroid Cancer Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Thyroid Cancer Diagnostic Major Product Offerings
  7.1.4 Abbott Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Thyroid Cancer Diagnostic Major Product Offerings
  7.2.4 Roche Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Thyroid Cancer Diagnostic Major Product Offerings
  7.3.4 Thermo Fisher Scientific Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 Siemens Healthcare GmbH
  7.4.1 Siemens Healthcare GmbH Corporate Summary
  7.4.2 Siemens Healthcare GmbH Business Overview
  7.4.3 Siemens Healthcare GmbH Thyroid Cancer Diagnostic Major Product Offerings
  7.4.4 Siemens Healthcare GmbH Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 Siemens Healthcare GmbH Key News
7.5 Bio-Rad Laboratories
  7.5.1 Bio-Rad Laboratories Corporate Summary
  7.5.2 Bio-Rad Laboratories Business Overview
  7.5.3 Bio-Rad Laboratories Thyroid Cancer Diagnostic Major Product Offerings
  7.5.4 Bio-Rad Laboratories Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Laboratories Key News
7.6 General Electric
  7.6.1 General Electric Corporate Summary
  7.6.2 General Electric Business Overview
  7.6.3 General Electric Thyroid Cancer Diagnostic Major Product Offerings
  7.6.4 General Electric Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 General Electric Key News
7.7 Koninklijke Philips
  7.7.1 Koninklijke Philips Corporate Summary
  7.7.2 Koninklijke Philips Business Overview
  7.7.3 Koninklijke Philips Thyroid Cancer Diagnostic Major Product Offerings
  7.7.4 Koninklijke Philips Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Koninklijke Philips Key News
7.8 Agilent Technologies
  7.8.1 Agilent Technologies Corporate Summary
  7.8.2 Agilent Technologies Business Overview
  7.8.3 Agilent Technologies Thyroid Cancer Diagnostic Major Product Offerings
  7.8.4 Agilent Technologies Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Agilent Technologies Key News
7.9 Illumina
  7.9.1 Illumina Corporate Summary
  7.9.2 Illumina Business Overview
  7.9.3 Illumina Thyroid Cancer Diagnostic Major Product Offerings
  7.9.4 Illumina Thyroid Cancer Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 Illumina Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Thyroid Cancer Diagnostic Market Opportunities & Trends in Global Market
Table 2. Thyroid Cancer Diagnostic Market Drivers in Global Market
Table 3. Thyroid Cancer Diagnostic Market Restraints in Global Market
Table 4. Key Players of Thyroid Cancer Diagnostic in Global Market
Table 5. Top Thyroid Cancer Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Thyroid Cancer Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Thyroid Cancer Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Thyroid Cancer Diagnostic Product Type
Table 9. List of Global Tier 1 Thyroid Cancer Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thyroid Cancer Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Thyroid Cancer Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Thyroid Cancer Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Thyroid Cancer Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Thyroid Cancer Diagnostic Product Offerings
Table 32. Abbott Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Thyroid Cancer Diagnostic Product Offerings
Table 35. Roche Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Thyroid Cancer Diagnostic Product Offerings
Table 38. Thermo Fisher Scientific Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. Siemens Healthcare GmbH Corporate Summary
Table 40. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Product Offerings
Table 41. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Laboratories Corporate Summary
Table 43. Bio-Rad Laboratories Thyroid Cancer Diagnostic Product Offerings
Table 44. Bio-Rad Laboratories Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. General Electric Corporate Summary
Table 46. General Electric Thyroid Cancer Diagnostic Product Offerings
Table 47. General Electric Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Koninklijke Philips Corporate Summary
Table 49. Koninklijke Philips Thyroid Cancer Diagnostic Product Offerings
Table 50. Koninklijke Philips Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Agilent Technologies Corporate Summary
Table 52. Agilent Technologies Thyroid Cancer Diagnostic Product Offerings
Table 53. Agilent Technologies Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Illumina Corporate Summary
Table 55. Illumina Thyroid Cancer Diagnostic Product Offerings
Table 56. Illumina Thyroid Cancer Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Thyroid Cancer Diagnostic Segment by Type in 2021
Figure 2. Thyroid Cancer Diagnostic Segment by Application in 2021
Figure 3. Global Thyroid Cancer Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Thyroid Cancer Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Thyroid Cancer Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thyroid Cancer Diagnostic Revenue in 2021
Figure 8. By Type - Global Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Thyroid Cancer Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Thyroid Cancer Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Siemens Healthcare GmbH Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Laboratories Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. General Electric Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Koninklijke Philips Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Agilent Technologies Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Illumina Thyroid Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)